Putnam BioRevolution ETF (SYNB)

Overview

The company operates as an investment fund primarily focused on the burgeoning sector of the “biology revolution.” By investing predominantly in common stocks, whether they are categorized as growth or value stocks, the fund seeks to capitalize on the rapid advancements and innovations within the biology-related fields. Companies of any size worldwide, which are directly involved in or benefit significantly from the biology revolution, form the core of the fund’s investment portfolio. This revolution encompasses a broad range of industries, including but not limited to health care, consumer discretionary, consumer staples, biotechnology, and materials sectors. Given the dynamic nature of these industries and the potential for significant technological advancements, the fund occasionally allocates a substantial portion of its assets towards companies within a single sector or a few interconnected sectors, reflecting a strategic focus designed to maximize returns. It's important to note that the fund operates with a non-diversified status, which means it may invest a larger portion of its assets in fewer issuers than a diversified fund.

Products and Services

• Common Stocks Investment

  An integral part of the fund’s investment strategy involves purchasing common stocks from a diverse range of companies worldwide. These companies are primarily engaged in or benefit significantly from the advances in biological sciences. This includes both growth stocks, which are expected to grow at an above-average rate compared to other companies, and value stocks, which are believed to be undervalued in comparison to their actual financial performance or intrinsic value.

• Focus on Biology Revolution Companies

  The core investment philosophy of the fund is to channel investments into companies leading or supporting the biology revolution. This includes but is not limited to entities within the health care, biotechnology, consumer discretionary, consumer staples, and materials sectors. Companies that are at the forefront of technological and scientific advancements in biology stand to benefit from the fund’s investment, facilitating growth and innovation in their respective fields.

• Strategic Sector Investment

  Understanding the interconnected and rapidly evolving nature of industries related to the biology revolution, the fund occasionally concentrates a significant portion of its investments in companies operating within one or more related industries or sectors. This targeted investment approach allows the fund to leverage potential growth opportunities and technological advancements in specific sectors, potentially enhancing overall portfolio performance.